Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone–Secreting Pituitary Tumors and Their Association with Tumor Recurrence-Reference-Cited by-同舟云学术

Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone–Secreting Pituitary Tumors and Their Association with Tumor Recurrence

Published:2018-05 Issue: Volume:113 Page:e213-e221
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Liu Xiaohai,Feng Ming,Zhang Ye,Dai Congxin,Sun Bowen,Bao Xinjie,Deng Kan,Yao Yong,Wang Renzhi

Publisher

Elsevier BV

Subject

Clinical Neurology,Surgery

Reference37 articles.

1. Diagnosis and complications of Cushing’s syndrome: a consensus statement;Arnaldi;J Clin Endocrinol Metab,2003

2. The basophil adenomas of the pituitary body and their clinical manifestations;Cushing;Bull Johns Hopkins Hosp,1932

3. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study;Clayton;Lancet Diabetes Endocrinol,2016

4. Cushing's syndrome;Lacroix;Lancet,2015

5. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement;Biller;J Clin Endocrinol Metab,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine;Biomedicines;2023-12-21

2. Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways;International Journal of Molecular Sciences;2023-10-29

3. Recurrent Cushing’s Disease in Adults: Predictors and Long-Term Follow-Up;Hormone and Metabolic Research;2023-04-04

4. Prognostic Biomarkers in Pituitary Tumours: A Systematic Review;touchREVIEWS in Endocrinology;2023

5. Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions;Diagnostics;2022-04-13